Login
$ASPI
$1.55 +$0.01 (0.65%) After hours

$ASPI SEC Filings

Filed On Filing
16 Nov 2026 10-Q
16 Nov 2026 SCHEDULE 13G/A
16 Nov 2026 SCHEDULE 13G/A
06 Nov 2026 425
05 Nov 2026 425
26 Oct 2026 FORM 425
26 Oct 2026 8-K: Regulation FD Disclosure

Phase 1 plant now in stable operation following commissioning; first liquid helium in storage ahead of initial deliveries to contracted offtakers

21 Oct 2026 Form 4: Kiessling Heather, Chief Financial Officer

Sold 21,830 shares ($47.8K)

16 Oct 2026 Form 4: Ainscow Robert, COO

Sold 22,500 shares ($47.6K)

16 Oct 2026 144
15 Oct 2026 8-K: Regulation FD Disclosure

Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa

14 Oct 2026 144
08 Oct 2026 Form 3: Asp Isotopes Inc., 10% owner and 1 other · ENDRA Life Sciences Inc.

Holds 66,846 shares of Common Stock

08 Oct 2026 SCHEDULE 13D
02 Oct 2026 8-K: Regulation FD Disclosure

As previously disclosed, on June 25, 2026, ASP Isotopes Inc., a Delaware corporation (“ASPI” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among ENDRA Life Sciences Inc., a Delaware corp...

01 Oct 2026 Form 4: Ryan Robert John Andrew, Director

Bought 15,000 shares ($40.2K)

30 Sep 2026 Form 4: Ryan Robert John Andrew, Director

Bought 8,000 shares ($21.6K)

25 Sep 2026 144
10 Sep 2026 Form 4: Ainscow Robert, COO

Sold 8,438 shares ($36.2K)

09 Sep 2026 425

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support